Journals / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 5

Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial

Pages
378–383
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The patient satisfaction was 87% in polidocanol group versus 73% in phenol group (p=0.040).Conclusion: 3% polidocanol is safe and more effective than 5% phenol in oil when used as injection sclerotherapy in the treatment of first and second-degree internal hemorrhoids.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Management of Haemorrhoids is suboptimal and is largely based on traditional practices in the Indian population.
📊
Key Findings & Data:The study was done to compare the safety and efficacy of a standard sclerosant (polidoca-nol) and the conventionally used phenol in oil in bleeding grade-1 and 2 internal haemorrhoids.Materials and Methods: All patients with grade-1 and 2 hemorrhoids, were selected and randomised into two groups, 3% polidocanol and 5% phenol group.
💡
Conclusion & Impact:The patient satisfaction was 87% in polidocanol group versus 73% in phenol group (p=0.040).Conclusion: 3% polidocanol is safe and more effective than 5% phenol in oil when used as injection sclerotherapy in the treatment of first and second-degree internal hemorrhoids.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: Management of Haemorrhoids is suboptimal and is largely based on traditional practices in the Indian population. Though injection sclerotherapy is a well-accepted treatment modality in early grade haemorrhoids, there is no consensus on the effec-tiveness of the drugs used for sclerotherapy. The study was done to compare the safety and efficacy of a standard sclerosant (polidoca-nol) and the conventionally used phenol in oil in bleeding grade-1 and 2 internal haemorrhoids.Materials and Methods: All patients with grade-1 and 2 hemorrhoids, were selected and randomised into two groups, 3% polidocanol and 5% phenol group. All patients were followed-up for three months and observed for “free of bleeding” or “persistent bleeding.” Pain, pruritus and patient satisfaction following the procedure was also assessed.Results: A total of 150 patients were enrolled, 75 in each group. At the end of the first sclerotherapy session with polidocanol, 60.6% of patients versus 38.1% in phenol group had stopped per rectal bleeding (p=0.009). After the second sclerotherapy session, 94.7% of patients in the polidocanol group and 84% of patients in the phenol group were treated successfully. Polidocanol group required signifi-cantly fewer treatment sessions than the phenol group (1.39±0.49 vs. 1.62±0.49; p=0.035), and the total volume of injected sclerosant was also less (3.30±0.96 mL vs. 4.86±1.46 mL; p=0.001). The patient satisfaction was 87% in polidocanol group versus 73% in phenol group (p=0.040).Conclusion: 3% polidocanol is safe and more effective than 5% phenol in oil when used as injection sclerotherapy in the treatment of first and second-degree internal hemorrhoids.

🔖

Cite This Article

MİSHRA, S., SAHOO, A. K., ELAMURUGAN, T. P., JAGDISH, S. (2020). Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 5, 378–383. https://ajindex.com/articles/408672

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. in improving hemorrhoid stages and relieving symptoms among patients with haemorrhoids. J Am Sci 2011; 7: 53-65. 2. Riss S, Weiser FA, Schwameis K, et al. The prevalence of hemorrhoids in adults. Int J Colorectal Dis 2012; 27: 215-20. [CrossRef] 3. Sneider EB, Maykel JA. Diagnosis and Management of Symptomatic Haemorrhoids. Surg Clin North Am 2010; 90: 17-32. [CrossRef] 4. Khubchandani I, Paonessa N, Khwaja A. Surgical Treatment of Hemorrhoids. 2nd ed. London: Springer; 2009.p.185. [CrossRef] 5. Moser KH, Mosch C, Walgenbach M, et al. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial. Int J Colorectal Dis 2013; 28: 1439-47. [CrossRef] 6. Mukhopadhyay M, Roy A, Piplai G, et al. Effectivity of Injection Sclerotherapy with Polidocanol in Early Haemorrhoids. J Evol Med Dent Sci 2014; 3: 6619-22. [CrossRef] 7. Yuksel BC, Armagan H, Berkem H, Yildiz Y, Ozel H, Hengirmen S. Conservative management of hemorrhoids: a comparison of venotonic flavonoid micronized purified flavonoid fraction (MPFF) and sclerotherapy. Surg Today 2008; 38: 123-9. [CrossRef] 8. Akerud L. Sclerotherapy of Haemorrhoids: A Prospective Randomised Trial of Polidocanol and Phenol in Oil. Coloproctology 1995; 17: 73-86. 9. Palit V, Biyani CS, Kay CL, Shah T. Prostato-cutaneous fistula following injection of internal haemorrhoids with oily phenol. Int Urol Nephrol 2001; 33: 509-10. [CrossRef] 10. Suppiah A, Perry E. Jaundice as a presentation of phenol induced hepatotoxicity following injection sclerotherapy for haemorrhoids. Surg J R Coll Surg Edinb Irel 2005; 3: 43-4. [CrossRef] 11. Kulshrestha L. Role of Polidocanol as Sclerosing Agent in Early Haemorrhoids. Surg J 2012; 7: 5-7. 12. Bhuiya M, Rahman S, Ali A. Effectivity of Injection Sclerotherapy on Early Haemorrhoids Reported to Surgical Outpatient Department. J Armed Forces Med Coll Bangladesh 2010; 6: 25-7. [CrossRef] 13. Nijhawan S, Udawat H, Gupta G, Sharma A, Mathur A, Sapra B, Nepalia S. Flexible video-endsocopic injection sclerotherapy for second and third degree internal haemorrhoids. J Dig Endosc 2011; 2: 1-5. [CrossRef] 14. Akindiose C, Alatise O, Arowolo O, Agbakwuru A. Evaluation of two injection sclerosants in the treatment of symptomatic haemorrhoids in Nigerians. Niger Postgrad Med J 2016; 23: 110-5. [CrossRef]